British Journal of Cancer - Table of Contents alert Volume 111 Issue 10

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 111, Issue 10 (1881-2032) Published online 11 November 2014 In this issue Minireviews Clinical Studies Translational Therapeutics Molecular Diagnostics Genetics and Genomics Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe Minireviews Top The AURORA initiative for metastatic breast cancer D Zardavas, M Maetens, A Irrthum, T Goulioti, K Engelen, D Fumagalli, R Salgado, P Aftimos, K S Saini, C Sotiriou, P Campbell, P Dinh, G von Minckwitz, R D Gelber, M Dowsett, A Di Leo, D Cameron, J Baselga, M Gnant, A Goldhirsch, L Norton and M Piccart Br J Cancer 2014 111: 1881-1887; advance online publication, September 16, 2014; 10.1038/bjc.2014.341 Abstract | Full Text HER2-positive advanced breast cancer: optimizing patient outcomes and opportunities for drug development J C Singh, K Jhaveri and F J Esteva Br J Cancer 2014 111: 1888-1898; advance online publication, July 15, 2014; 10.1038/bjc.2014.388 Abstract | Full Text Clinical Studies Top Survivorship care plans in cancer: a systematic review of care plan outcomes M E Brennan, J F Gormally, P Butow, F M Boyle and A J Spillane Br J Cancer 2014 111: 1899-1908; advance online publication, October 14, 2014; 10.1038/bjc.2014.505 Abstract | Full Text Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma A B Suttle, H A Ball, M Molimard, T E Hutson, C Carpenter, D Rajagopalan, Y Lin, S Swann, R Amado and L Pandite Br J Cancer 2014 111: 1909-1916; advance online publication, October 28, 2014; 10.1038/bjc.2014.503 Abstract | Full Text α-Smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 study M Sinn, C Denkert, J K Striefler, U Pelzer, J M Stieler, M Bahra, P Lohneis, B Dörken, H Oettle, H Riess and B V Sinn Br J Cancer 2014 111: 1917-1923; advance online publication, October 14, 2014; 10.1038/bjc.2014.495 Abstract | Full Text Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer M Michael, S Chander, J McKendrick, J R MacKay, M Steel, R Hicks, A Heriot, T Leong, P Cooray, M Jefford, J Zalcberg, M Bressel, B McClure and S Y Ngan Br J Cancer 2014 111: 1924-1931; advance online publication, September 11, 2014; 10.1038/bjc.2014.487 Abstract | Full Text A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours I Brana, R Berger, T Golan, P Haluska, J Edenfield, J Fiorica, J Stephenson, L P Martin, S Westin, P Hanjani, M B Jones, K Almhanna, R M Wenham, D M Sullivan, W S Dalton, A Gunchenko, J D Cheng, L L Siu and J E Gray Br J Cancer 2014 111: 1932-1944; advance online publication, October 7, 2014; 10.1038/bjc.2014.497 Abstract | Full Text Translational Therapeutics Top Direct incorporation of the NKT-cell activator α-galactosylceramide into a recombinant Listeria monocytogenes improves breast cancer vaccine efficacy M Singh, W Quispe-Tintaya, D Chandra, A Jahangir, M M Venkataswamy, T W Ng, S Sharma-Kharkwal, L J Carreño, S A Porcelli and C Gravekamp Br J Cancer 2014 111: 1945-1954; advance online publication, October 14, 2014; 10.1038/bjc.2014.486 Abstract | Full Text Differential response of head and neck cancer cell lines to TRAIL or Smac mimetics is associated with the cellular levels and activity of caspase-8 and caspase-10 N Raulf, R El-Attar, D Kulms, D Lecis, D Delia, H Walczak, K Papenfuss, E Odell and M Tavassoli Br J Cancer 2014 111: 1955-1964; advance online publication, October 14, 2014; 10.1038/bjc.2014.521 Abstract | Full Text Shed Syndecan-1 is involved in chemotherapy resistance via the EGFR pathway in colorectal cancer X Wang, D Zuo, Y Chen, W Li, R Liu, Y He, L Ren, L Zhou, T Deng, X Wang, G Ying and Y Ba Br J Cancer 2014 111: 1965-1976; advance online publication, October 16, 2014; 10.1038/bjc.2014.493 Abstract | Full Text Molecular Diagnostics Top HER2/neu testing in primary colorectal carcinoma B Ingold Heppner, H-M Behrens, K Balschun, J Haag, S Krüger, T Becker and C Röcken Br J Cancer 2014 111: 1977-1984; advance online publication, September 11, 2014; 10.1038/bjc.2014.483 Abstract | Full Text Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma G Zheng, L Du, X Yang, X Zhang, L Wang, Y Yang, J Li and C Wang Br J Cancer 2014 111: 1985-1992; advance online publication, September 18, 2014; 10.1038/bjc.2014.489 Abstract | Full Text Serpin peptidase inhibitor clade A member 1 is a biomarker of poor prognosis in gastric cancer C H Kwon, H J Park, J R Lee, H K Kim, T Y Jeon, H-J Jo, D H Kim, G H Kim and D Y Park Br J Cancer 2014 111: 1993-2002; advance online publication, September 11, 2014; 10.1038/bjc.2014.490 Abstract | Full Text MicroRNA-183 promotes proliferation and invasion in oesophageal squamous cell carcinoma by targeting programmed cell death 4 L-H Ren, W-X Chen, S Li, X-Y He, Z-M Zhang, M Li, R-S Cao, B Hao, H-J Zhang, H-Q Qiu and R-H Shi Br J Cancer 2014 111: 2003-2013; advance online publication, September 11, 2014; 10.1038/bjc.2014.485 Abstract | Full Text Genetics and Genomics Top Clinical massively parallel next-generation sequencing analysis of 409 cancer-related genes for mutations and copy number variations in solid tumours R R Singh, K P Patel, M J Routbort, K Aldape, X Lu, J Manekia, R Abraham, N G Reddy, B A Barkoh, J Veliyathu, L J Medeiros and R Luthra Br J Cancer 2014 111: 2014-2023; advance online publication, October 14, 2014; 10.1038/bjc.2014.518 Abstract | Full Text TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations M Labussière, A L Di Stefano, V Gleize, B Boisselier, M Giry, S Mangesius, A Bruno, R Paterra, Y Marie, A Rahimian, G Finocchiaro, R S Houlston, K Hoang-Xuan, A Idbaih, J-Y Delattre, K Mokhtari and M Sanson Br J Cancer 2014 111: 2024-2032; advance online publication, October 14, 2014; 10.1038/bjc.2014.538 Abstract | Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.